HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45649,
"recordsTotal": 45649,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=registry_id&start=43500",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=registry_id&start=42900",
"results": [
{
"registry_id": "NCT06384807",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06384807",
"title": "A Phase 1/2, First in Human, Dose Escalation and Dose Expansion Study of BHV-1510 (Previously PBI-410) as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-04-22",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biohaven Therapeutics Ltd.",
"sponsor_slug": "biohaven-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504147",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06504147",
"title": "A Phase 2, Randomised, Open Label, Multicentre Study of an Intraperitoneal Α-emitting Radionuclide Therapy (Radspherin®) in Patients with Primary Advanced High-grade Serous or High-grade Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, with Peritoneal Metastasis That Are Homologous Recombination Proficient and Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery",
"has_exemption": false,
"start_date": "2024-06-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Oncoinvent AS",
"sponsor_slug": "oncoinvent-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06496178",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06496178",
"title": "A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared With Investigator's Choice Monotherapy Treatment in Previously Treated Patients With Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus N.V.",
"sponsor_slug": "merus-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06437574",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06437574",
"title": "Lowering Cholesterol in Prostate Cancer to Target Rapamycin-Insensitive Companion of MTOR (TORC2) in T-Cell Surface Glycoprotein CD8 Alpha Chain (CD8+) Lymphocytes",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06310031",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06310031",
"title": "Investigation of a Novel, magNetically Levitated VAD for the Treatment of refractOry Left Ventricular heArT failurE",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BrioHealth Solutions, Inc.",
"sponsor_slug": "briohealth-solutions-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06532656",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06532656",
"title": "A Phase 2/3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1",
"has_exemption": false,
"start_date": "2024-11-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336798",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06336798",
"title": "Effect of Pioglitazone on Mitochondrial Metabolism in Pulmonary Hypertension Due to Chronic Lung Disease",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568939",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06568939",
"title": "A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-01-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06092333",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06092333",
"title": "A Pilot Study of the Combination of VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699602",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06699602",
"title": "A Pilot Phase II Study of Neoadjuvant Cemiplimab + Fianlimab in Patients With Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06534060",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06534060",
"title": "A Phase 2, Open-label, Multicenter Study of MB-105 in Patients With CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL).",
"has_exemption": false,
"start_date": "2025-02-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "March Biosciences Inc",
"sponsor_slug": "march-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06860386",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06860386",
"title": "A Phase II Study Assessing the Feasibility and Clinical Efficacy of Adaptive Immunotherapy Combination With VEGFR-TKI in Patients With Advanced Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824792",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06824792",
"title": "Real-world Study to Investigate Optimal Standard Treatment Selection for Solid Tumor Patients by Guided by Biologically-informed Multi-agent System",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "NING LI",
"sponsor_slug": "ning-li",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902311",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06902311",
"title": "Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801639",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06801639",
"title": "Advancing Alzheimer's Care: Home-based tDCS (Transcranial Direct Current Stimulator) for Affective Symptoms",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06062888",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06062888",
"title": "Multi-institutional Phase 2/3 Trial of Fresh Frozen Plasma (FFP) in Patients With Moderate to Severe Traumatic Brain Injury (TBI)",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06522737",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06522737",
"title": "A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SecuraBio",
"sponsor_slug": "securabio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06800963",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06800963",
"title": "ResQ133A-NMIBC: Phase 1/2 Clinical Trial of Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730283",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05730283",
"title": "Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin Therapy for Pulmonary Non-Tuberculous Mycobacterium Disease",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kevin Winthrop",
"sponsor_slug": "kevin-winthrop",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891781",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06891781",
"title": "A Prospective, Multi-center, Randomized, Double-blind, Cross Over, Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Stimulation in Levodopa- Responsive Parkinson's Disease Treated with Bilateral Deep Brain Stimulation of the Subthalamic Nucleus",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Newronika",
"sponsor_slug": "newronika",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995677",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06995677",
"title": "A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855277",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06855277",
"title": "A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925321",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06925321",
"title": "An Interventional Phase 3, Open-label, Two-cohort Study to Investigate the Efficacy and Safety of Fosmanogepix in Adult Patients With Invasive Mold Infections Caused by Aspergillus Spp., Fusarium Spp., Lomentospora Prolificans, Mucorales Fungi, or Other Multidrug Resistant Molds",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Basilea Pharmaceutica",
"sponsor_slug": "basilea-pharmaceutica",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07055594",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07055594",
"title": "A Phase I/IIa Dose-escalation, Dose-optimization and Dose Expansion Study to Evaluate the Safety and Preliminary Efficacy of Tri-specific Antibody (SOA101) in Subjects With Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Shine-On Biomedical Co., Ltd.",
"sponsor_slug": "shine-on-biomedical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521476",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06521476",
"title": "Impact of Acetazolamide on Central Sleep Apnea Patients Receiving Medication for Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanjay R Patel",
"sponsor_slug": "sanjay-r-patel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029581",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07029581",
"title": "A Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06743113",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06743113",
"title": "A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE® System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Hemanext",
"sponsor_slug": "hemanext",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04404088",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04404088",
"title": "A Phase II Study of Acalabrutinib, Lenalidomide, and Rituximab (aR2) in Patients With Previously Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2020-07-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04941274",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04941274",
"title": "A Phase I/II Study of Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05488431",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05488431",
"title": "Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)",
"has_exemption": false,
"start_date": "2023-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Priscilla Hsue, MD",
"sponsor_slug": "priscilla-hsue-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05727904",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05727904",
"title": "A Phase 3, Multicenter, Randomized, Open-label, Parallel Group, Treatment Study to Assess the Efficacy and Safety of the Lifileucel (LN-144, Autologous Tumor Infiltrating Lymphocytes [TIL]) Regimen in Combination With Pembrolizumab Compared With Pembrolizumab Monotherapy in Participants With Untreated, Unresectable or Metastatic Melanoma",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05706025",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05706025",
"title": "Pilot Study to Evaluate Utility of EnteroTracker® as a Minimally Invasive Sampling Method to Screen for Barrett's Esophagus and Esophageal Cancer",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06633913",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06633913",
"title": "Neural Effects of Transcranial Magnetic Stimulation Using Concurrent Functional Magnetic Resonance Imaging",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jing Jiang",
"sponsor_slug": "jing-jiang",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06275776",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06275776",
"title": "The Effect of Suturing Techniques on Aberrant Wound Recovery After Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Reinier Haga Orthopedisch Centrum",
"sponsor_slug": "reinier-haga-orthopedisch-centrum",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157099",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06157099",
"title": "A Decentralized Phase II Randomized Controlled Trial of Atorvastatin in Resected High-Risk Melanoma",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06578741",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06578741",
"title": "GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06398106",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06398106",
"title": "Proactive Therapeutic Drug Monitoring Versus Routine Care With the Novel Biologics in Psoriasis : a Pragmatic, Multicentric, Randomised, Controlled Study",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Ghent",
"sponsor_slug": "university-hospital-ghent",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06675344",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06675344",
"title": "A Randomized, Double-blind, Clinical Trial of the Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Robyn T. Domsic, MD, MPH",
"sponsor_slug": "robyn-t-domsic-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06563596",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06563596",
"title": "A Phase 2 Study of Epcoritamab, Zanubrutinib, and Rituximab (EZR) for Treatment of Relapsed or Refractory Follicular Lymphoma or Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Reid Merryman, MD",
"sponsor_slug": "reid-merryman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06592833",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06592833",
"title": "Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06580054",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06580054",
"title": "Pembrolizumab for Orbital and Periocular Cutaneous Squamous Cell Carcinoma (cSCC)",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377215",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06377215",
"title": "Understanding Aided Speech Perception in Noise: Behavioral and Electrophysiological Measures",
"has_exemption": false,
"start_date": "2025-03-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of South Florida",
"sponsor_slug": "university-of-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959511",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06959511",
"title": "Neoadjuvant Treatment With Zanzalintinib for Advanced Thyroid Cancer",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07025330",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07025330",
"title": "A Phase IIa, Single-Site, Open-Label Study of Efgartigimod in Patients With IgG4-Related Disease",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06849713",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06849713",
"title": "A Phase 2 Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06367361",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06367361",
"title": "Non-inferiority, Controlled, Randomized, Single-blind Study for Compare Regimens of One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole to Treat Chronic Fascioliasis",
"has_exemption": false,
"start_date": "2025-08-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universidad Peruana Cayetano Heredia",
"sponsor_slug": "universidad-peruana-cayetano-heredia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03571945",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03571945",
"title": "Impact of Bi-spectral Index Guided Inhalation Anaesthesia on the Incidence of Intraoperative Awareness in Indian Patient Population: A Prospective, Randomised, Multi-Centric Study",
"has_exemption": false,
"start_date": "2018-10-10",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Sir Ganga Ram Hospital",
"sponsor_slug": "sir-ganga-ram-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05682378",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05682378",
"title": "An Open-label, Single Arm, Multicenter Extension Study to Evaluate Long-term Safety and Tolerability of Inclisiran in Participants With Heterozygous or Homozygous Familial Hypercholesterolemia Who Have Completed the Adolescent ORION-16 or ORION-13 Studies (VICTORION-PEDS-OLE)",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06676579",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06676579",
"title": "A Multi-Center, Phase II, Open Label, Randomized Trial Evaluating the Efficacy and Safety of Complement 5a Receptor Antagonist Avacopan in Crescentic IgA Nephropathy",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05834296",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05834296",
"title": "Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 1/2a Study to Assess Safety, Tolerability & Efficacy of Autologous Beta-Amyloid Mutant Peptide-pulsed Dendritic Cells in Subjects With Mild-to-Moderate Alzheimer's Dementia",
"has_exemption": false,
"start_date": "2023-07-05",
"completion_date": "2028-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Alzamend Neuro, Inc.",
"sponsor_slug": "alzamend-neuro-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375800",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04375800",
"title": "A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Participants With HIV-1, Who Are 4 Weeks to Less Than 12 Years of Age and Weigh Less Than 45 kg",
"has_exemption": false,
"start_date": "2021-02-03",
"completion_date": "2028-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06283966",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06283966",
"title": "A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)",
"has_exemption": false,
"start_date": "2024-02-21",
"completion_date": "2028-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06928662",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06928662",
"title": "Sequential Decitabine in Combination With FLAG-Ida Followed Immediately by Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (DEC-FLAG-Ida/RIC) for Adults With Myeloid Malignancies at High Risk of Relapse: A Phase 1/2 Study",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04276870",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04276870",
"title": "CD19-Directed Chimeric Antigen Receptor CD19 Redirected Autologous T Cells (CART19) for Orphan Indications of Pediatric B Cell Acute Lymphoblastic Leukemia (B ALL)",
"has_exemption": false,
"start_date": "2020-03-12",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephan Grupp MD PhD",
"sponsor_slug": "stephan-grupp-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06403644",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06403644",
"title": "Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices",
"has_exemption": false,
"start_date": "2024-03-11",
"completion_date": "2028-03-11",
"has_results": false,
"results_due": false,
"sponsor_name": "United States Air Force Research Laboratory",
"sponsor_slug": "united-states-air-force-research-laboratory",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926868",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06926868",
"title": "A Randomized, Open-label, Inferentially Seamless Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable,or Metastatic Triple-negative Breast Cancer (TNBC)or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06453044",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06453044",
"title": "A Phase 2 Study of Mosunetuzumab with Polatuzumab Vedotin in Patients with Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06245109",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06245109",
"title": "Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2024-02-26",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06616766",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06616766",
"title": "A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, PK and Anti-tumor Activity of YH42946 in Patients With Locally Advanced or Metastatic Solid Tumors With HER2 Aberration and EGFR Exon 20 Insertion",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Yuhan Corporation",
"sponsor_slug": "yuhan-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06605105",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06605105",
"title": "A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants With Major Depressive Disorder (EXTEND)",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Cybin IRL Limited",
"sponsor_slug": "cybin-irl-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06495125",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06495125",
"title": "A Phase 2 Study of Defactinib and Avutometinib, in Combination With Nivolumab for Patients With Anti-PD1 Refractory LKB1-Mutant Advanced Lung Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305247",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06305247",
"title": "An Open-label, Phase I/IIa First-in-human, Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Antitumour Activity of ERK1/2 Inhibitor IPN01194 as Single Agent in Adult Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2028-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042569",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06042569",
"title": "Dose Reduction of Docetaxel-Based Chemotherapy in Vulnerable Older Women With Early-Stage Breast Cancer (DOROTHY)",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2028-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05160922",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05160922",
"title": "CRIZOTINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED CRIZOTINIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2021-12-27",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04804553",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04804553",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)",
"has_exemption": false,
"start_date": "2022-03-17",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06350097",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06350097",
"title": "A Phase III, Open-label, Randomised Study of Osimertinib With or Without Datopotamab Deruxtecan (Dato-DXd), as First-line Treatment in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation-positive, Locally Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597019",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06597019",
"title": "Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children (6 to Less Than 12 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL- Cholesterol",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597006",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06597006",
"title": "Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Children (2 to Less Than 12 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616910",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05616910",
"title": "Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06939348",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06939348",
"title": "Safety and Efficacy of Thalamic Focused Ultrasound Stimulation (tFUS) for Promoting Recovery After Severe Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-04-26",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05316155",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05316155",
"title": "Phase 1/2 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants With Non-Muscle-Invasive or Muscle-Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2022-04-11",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05811364",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05811364",
"title": "The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease",
"has_exemption": false,
"start_date": "2023-10-17",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06091865",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06091865",
"title": "A Phase 3, Open Label, Randomized Study Comparing the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 × Anti-CD3 Bispecific Antibody, in Combination With CHOP (ODRO-CHOP) Versus Rituximab in Combination With CHOP (R-CHOP) in Previously Untreated Participants With Diffuse Large B-cell Lymphoma (DLBCL) (OLYMPIA-3)",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06213324",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06213324",
"title": "Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644768",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06644768",
"title": "A Multicenter, Randomized, Open-Label, Phase 1b/2 Trial Of Valemetostat Tosylate Plus Pembrolizumab Vs Pembrolizumab Alone in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 With Tumor Proportion Score ≥50% Without Actionable Genomic Alterations",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06565507",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06565507",
"title": "A Double-blind Multicenter, Randomized Controlled Trial of Single and Multiple Dose Regimens of Oxfendazole for Mild (One or Two Lesions) Parenchymal Brain Cysticercosis, With an Open Comparison Group",
"has_exemption": false,
"start_date": "2024-12-15",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Universidad Peruana Cayetano Heredia",
"sponsor_slug": "universidad-peruana-cayetano-heredia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06905054",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06905054",
"title": "Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07012057",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07012057",
"title": "A Phase II Open-Label Study of Deucravacitinib for Refractory Adults With Dermatomyositis/ Juvenile Dermatomyositis",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)",
"sponsor_slug": "national-institute-of-arthritis-and-musculoskeletal-and-skin-diseases-niams",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03514329",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03514329",
"title": "Vapor Ablation for Localized Cancer Lesions of the Lung - A Clinical Feasibility Definitive Treatment Study",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Uptake Medical Technology, Inc.",
"sponsor_slug": "uptake-medical-technology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02710968",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02710968",
"title": "Study of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2015-08-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02742883",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02742883",
"title": "A Phase 2 Study of Atengenal (A-10) and Astugenal (AS2-1) in Diffuse, Intrinsic Pontine Glioma (DIPG)",
"has_exemption": false,
"start_date": "2016-04-13",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Burzynski Research Institute",
"sponsor_slug": "burzynski-research-institute",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03294863",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03294863",
"title": "Use of Embrace Device After Cutaneous Wound Closure: a Randomized Evaluator Blinded Split Wound Comparative Effectiveness Trial",
"has_exemption": false,
"start_date": "2017-03-15",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03682289",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03682289",
"title": "Phase II Trial of Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Selected Solid Tumor Malignancies",
"has_exemption": false,
"start_date": "2019-01-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rahul Aggarwal",
"sponsor_slug": "rahul-aggarwal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04261712",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04261712",
"title": "An Open Label, Long-term Extension Study to Evaluate the Safety and Efficacy of CRN00808 in Subjects With Acromegaly (ACROBAT Advance)",
"has_exemption": false,
"start_date": "2019-01-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crinetics Pharmaceuticals Inc.",
"sponsor_slug": "crinetics-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03865290",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03865290",
"title": "Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia",
"has_exemption": false,
"start_date": "2019-04-02",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03998254",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03998254",
"title": "A Phase 3 Randomized, Double-Blinded, Controlled With GARDASIL® Efficacy, Immunogenicity and Safety Study of V503 [a 9-Valent HPV Vaccine] in Chinese Women 20 to 45 Years of Age",
"has_exemption": false,
"start_date": "2019-06-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04560803",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04560803",
"title": "Using Autologous Epidermal Skin Micrografts to Improve Healing In Radiation Wounds: A Pilot Study",
"has_exemption": false,
"start_date": "2021-01-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04639050",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04639050",
"title": "A Phase Ib/IIa, Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Patients With Prodromal or Mild to Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04696029",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04696029",
"title": "Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma",
"has_exemption": false,
"start_date": "2021-03-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04848506",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04848506",
"title": "A Follow-Up, Open-Label, Research Evaluation of Sustained Treatment With Aficamten (CK-3773274) in Hypertrophic Cardiomyopathy (HCM)",
"has_exemption": false,
"start_date": "2021-05-06",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04486833",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04486833",
"title": "A Phase 1/2 Open-Label, Dose-Escalation and Clinical Response Study of Quaratusugene Ozeplasmid in Combination With Osimertinib in Patients With Advanced, Metastatic EGFR-Mutant, Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2021-09-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genprex, Inc.",
"sponsor_slug": "genprex-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05150704",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05150704",
"title": "Single Blind Randomized Controlled Trial to Assess the Safety and Efficacy of High Dose Pulse Intravenous Corticosteroid Therapy to Treat Patients With Complicated/Fulminant Acute Myocarditis",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Niguarda Hospital",
"sponsor_slug": "niguarda-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04982419",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04982419",
"title": "Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04853251",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04853251",
"title": "A Phase IV, Multicenter, Open-Label Study to Assess Corneal Endothelial Cells in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System With Ranibizumab (PDS)",
"has_exemption": false,
"start_date": "2021-12-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04840602",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04840602",
"title": "A Phase II Randomized Study Comparing Ibrutinib and Rituximab vs. Venetoclax and Rituximab in Previously Untreated Waldenström's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL)",
"has_exemption": false,
"start_date": "2022-01-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04977180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04977180",
"title": "Phase II Trial of Cardioprotective Prophylaxis With Combination of Beta Blocker and Angiotensin-Converting Enzyme Inhibitors During Intensive Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2022-03-04",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04928846",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04928846",
"title": "A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2022-03-25",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05376267",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05376267",
"title": "Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)",
"has_exemption": false,
"start_date": "2022-08-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05623020",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05623020",
"title": "MAGNETISMM-6: AN OPEN-LABEL, 2-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) + DARATUMUMAB + LENALIDOMIDE OR ELRANATAMAB + LENALIDOMIDE VERSUS DARATUMUMAB + LENALIDOMIDE + DEXAMETHASONE IN TRANSPLANT-INELIGIBLE PARTICIPANTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA",
"has_exemption": false,
"start_date": "2022-11-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05549297",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05549297",
"title": "Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination With Pembrolizumab Versus Investigator's Choice in HLA-A*02:01-positive Participants With Previously Treated Advanced Melanoma (TEBE-AM)",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunocore Ltd",
"sponsor_slug": "immunocore-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05884411",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05884411",
"title": "Evaluation of Left Bundle Branch Area Pacing As A Rescue Strategy for Cardiac Resynchronization Therapy Non-response in Patients With Heart Failure: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2023-04-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05711394",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05711394",
"title": "A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Episodic Migraine in Pediatric Subjects 6-17 Years of Age.",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05889182",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05889182",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05871372",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05871372",
"title": "Intracranial Investigation of Neural Circuity Underlying Human Mood",
"has_exemption": false,
"start_date": "2023-07-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796440",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05796440",
"title": "An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06019949",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06019949",
"title": "Neuromodulatory Rehabilitation for Respiratory Motor Function in Individuals With Chronic Spinal Cord Injury",
"has_exemption": false,
"start_date": "2023-09-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05700903",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05700903",
"title": "Autonomic and Renal Contributions to Hypertension With Androgen Deprivation Therapy",
"has_exemption": false,
"start_date": "2023-09-20",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05848713",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05848713",
"title": "AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Manitoba",
"sponsor_slug": "university-of-manitoba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06001918",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06001918",
"title": "Randomized Controlled Clinical Trial (RCT) of the Nectero EAST System for Small to Mid-Sized Abdominal Aortic Aneurysms (AAA) StaBiLization: Evaluation of Efficacy.",
"has_exemption": false,
"start_date": "2023-10-25",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nectero Medical, Inc.",
"sponsor_slug": "nectero-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608408",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05608408",
"title": "Network Neuro-modulation for Mesial Temporal Lobe Epilepsy",
"has_exemption": false,
"start_date": "2023-11-16",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nitin Tandon",
"sponsor_slug": "nitin-tandon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06149403",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06149403",
"title": "A Multi-center, Randomized, Active Controlled Clinical Trial to Evaluate the Efficacy and Safety of OTL-203 in Subjects With Mucopolysaccharidosis Type I, Hurler Syndrome (MPS-IH) Compared to Standard of Care With Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orchard Therapeutics",
"sponsor_slug": "orchard-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05100641",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05100641",
"title": "Randomized Phase 3 Trial of Standard Care Plus AV-GBM-1 vs Autologous Monocytes as Adjunctive Therapy Following Primary Surgery Plus Concurrent Radiation-temozolomide in Patients With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aivita Biomedical, Inc.",
"sponsor_slug": "aivita-biomedical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06108934",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06108934",
"title": "A Prospective, Pre-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia Hip Stem in Total Hip Arthroplasty (THA)",
"has_exemption": false,
"start_date": "2024-02-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Australia Pty Ltd.",
"sponsor_slug": "stryker-australia-pty-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06223867",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06223867",
"title": "Evaluation of Efficacy, Effectiveness, and Implementation of Jaspr Health's Digital Platform in Emergency Department for Patients with Suicidal Risk- Part A: Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-23",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Massachusetts, Worcester",
"sponsor_slug": "university-of-massachusetts-worcester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06309264",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06309264",
"title": "Benefits of Speech-based Audiometry and Low-gain Hearing Aids for Blast-exposed Veterans",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05823532",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05823532",
"title": "Targeting Inflammation-Induced Changes in Brain Reward Signaling and Motivational Deficits in Patients With Schizophrenia Using an Anti-Inflammatory Challenge.",
"has_exemption": false,
"start_date": "2024-04-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06107062",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06107062",
"title": "Hemp-derived Cannabidiol for the Treatment of Cannabis Use Disorder: A Double-blind Placebo-controlled Randomized Trial",
"has_exemption": false,
"start_date": "2024-05-16",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06353386",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06353386",
"title": "MK-5684-01A Substudy: A Phase 1/2 Umbrella Substudy of MK-5684-U01 Master Protocol to Evaluate the Safety and Efficacy of MK-5684-based Treatment Combinations or MK-5684 Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05861986",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05861986",
"title": "A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Patients With Spinal Muscular Atrophy After Gene Therapy",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06388889",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06388889",
"title": "An Open-Label Long-Term Phase III Extension Study to Assess the Long-Term Safety and Tolerability of Dexpramipexole in Participants With Severe Eosinophilic Asthma",
"has_exemption": false,
"start_date": "2024-06-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Areteia Therapeutics",
"sponsor_slug": "areteia-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06442566",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06442566",
"title": "Sequential Trial of Adding Buprenorphine, Cognitive Behavioral Treatment, and Transcranial Magnetic Stimulation to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (ACTION)",
"has_exemption": false,
"start_date": "2024-08-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05861999",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05861999",
"title": "A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy",
"has_exemption": false,
"start_date": "2024-08-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06033950",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06033950",
"title": "A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Colorado Prevention Center",
"sponsor_slug": "colorado-prevention-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667701",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05667701",
"title": "Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rajesh Kumar",
"sponsor_slug": "rajesh-kumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06184750",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06184750",
"title": "Refining Tamoxifen Dose for Premenopausal Breast Cancer Risk Reduction (RENAISSANCE): A Phase II Single Arm Trial",
"has_exemption": false,
"start_date": "2024-09-27",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06272812",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06272812",
"title": "A Phase 2b, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine, MTBVAC, Against TB Disease in Interferon Gamma Release Assay Positive Adolescents and Adults Aged 14-45 Years, Living in a TB Endemic Region.",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "International AIDS Vaccine Initiative",
"sponsor_slug": "international-aids-vaccine-initiative",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679270",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06679270",
"title": "An Open-label Extension of APG-20 Study to Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With Partial Lipodystrophy",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amryt Pharma",
"sponsor_slug": "amryt-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04530058",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04530058",
"title": "The Effects of Metformin on Morbidity and Mortality in Elderly Patients- a Prospective Randomized Control Trial (RCT)",
"has_exemption": false,
"start_date": "2024-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hamilton Health Sciences Corporation",
"sponsor_slug": "hamilton-health-sciences-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855212",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06855212",
"title": "A Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06830044",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06830044",
"title": "A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Milsaperidone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanda Pharmaceuticals",
"sponsor_slug": "vanda-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06070012",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06070012",
"title": "Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06311214",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06311214",
"title": "Optimizing Antibody-Drug Conjugate Therapy Through Molecular Analysis for Therapy Choice (ADC MATCH)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06680258",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06680258",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of TPST-1120 in Combination With Atezolizumab Plus Bevacizumab Compared With Placebo Plus Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Not Previously Treated With Systemic Therapy",
"has_exemption": false,
"start_date": "2025-03-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tempest Therapeutics",
"sponsor_slug": "tempest-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699121",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06699121",
"title": "A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Study Evaluating the Safety and Efficacy of LB P8 in Patients With Primary Sclerosing Cholangitis (PSC)",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "LISCure Biosciences",
"sponsor_slug": "liscure-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06450925",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06450925",
"title": "A Randomized Double Blinded Trial of Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06485843",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06485843",
"title": "An Open Label Phase IIb Study to Evaluate Safety and Tolerability of OA-SYS in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint",
"has_exemption": false,
"start_date": "2025-04-02",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ageless Biotech, Inc.",
"sponsor_slug": "ageless-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06812832",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06812832",
"title": "Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Madigan Army Medical Center",
"sponsor_slug": "madigan-army-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820463",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06820463",
"title": "A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Telisotuzumab Adizutecan in Subjects With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06880770",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06880770",
"title": "Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis (SHASTA-5 Study)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arrowhead Pharmaceuticals",
"sponsor_slug": "arrowhead-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06579196",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06579196",
"title": "Evaluation of Trabedersen (OT-101) With Pembrolizumab in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer and Positive PD-L1",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06702553",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06702553",
"title": "Effect of Inhaled Nitric Oxide on Major Adverse Events Requiring Intensive Life Support in Adults Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Phase III, Double-Blind, Multicenter, Randomized Controlled Trial (Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass, the NORISC Trial)",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xijing Hospital",
"sponsor_slug": "xijing-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06682988",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06682988",
"title": "A Randomized Phase 2, Open-label Study of Mirvetuximab Soravtansine in Patients With Platinum-resistant Advanced High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-alpha Expression Testing 2 Schedules of Administration for Dose Optimization, With a Separate Cohort to Determine Starting Dose in Patients With Moderate Hepatic Impairment",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06340568",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06340568",
"title": "A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07075718",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07075718",
"title": "Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Glaukos Corporation",
"sponsor_slug": "glaukos-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872684",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06872684",
"title": "Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Neurovascular",
"sponsor_slug": "stryker-neurovascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951594",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06951594",
"title": "Iowa Cochlear Implant Clinical Research Center Study on Robotic-Assisted Versus Manual Electrode Array Insertion",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07045909",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07045909",
"title": "A Phase 2, Open-label, Multicenter Multi-cohort Study to Evaluate the Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06356155",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06356155",
"title": "A Phase II, Open-label, Single-arm, Multi-center Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer (NEPTUNE)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06850805",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06850805",
"title": "A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Optinose US Inc.",
"sponsor_slug": "optinose-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961344",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06961344",
"title": "An Open-label Extension Study Evaluating the Safety of Zagociguat in Participants With MELAS Who Completed TIS6463-203",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tisento Therapeutics",
"sponsor_slug": "tisento-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06842498",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06842498",
"title": "A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients With Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "FibroGen",
"sponsor_slug": "fibrogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959524",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06959524",
"title": "AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023835",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07023835",
"title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089576",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07089576",
"title": "A Prospective, Multi-center Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA in the Open Repair of Aortic Arch Aneurysms and Dissections",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Artivion Inc.",
"sponsor_slug": "artivion-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06708455",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06708455",
"title": "Phase 2 Trial of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy of PD-(L)1 Resistant Malignant Melanoma",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapa Therapeutics LLC",
"sponsor_slug": "rapa-therapeutics-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04901741",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04901741",
"title": "An Open-label Phase 2 Study of Olaptesed Pegol (NOX-A12) Combined With Pembrolizumab and Nanoliposomal Irinotecan/5-FU/Leucovorin or Gemcitabine/Nab-paclitaxel in Microsatellite-stable Metastatic Pancreatic Cancer Patients",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TME Pharma AG",
"sponsor_slug": "tme-pharma-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05402384",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05402384",
"title": "Evaluation of Efficacy and Safety of D-galactose Supplementation in SLC35A2-CDG, a Disorder of Hypogalactosylation",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eva Morava-Kozicz",
"sponsor_slug": "eva-morava-kozicz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03678025",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03678025",
"title": "Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2018-09-24",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03947450",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03947450",
"title": "Autologous Volar Fibroblast Injection Into the Stump Site of Amputees",
"has_exemption": false,
"start_date": "2019-09-05",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03984448",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03984448",
"title": "Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas",
"has_exemption": false,
"start_date": "2019-10-22",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764642",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05764642",
"title": "Renal Microvessel Imaging for Characterization of Chronic Kidney Disease",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06062875",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06062875",
"title": "Effects of TNF Blockade on Human BPH/LUTS",
"has_exemption": false,
"start_date": "2024-01-24",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endeavor Health",
"sponsor_slug": "endeavor-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06073665",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06073665",
"title": "Levothyroxine Dosing in Older Individuals",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06350045",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06350045",
"title": "Renal Puncture Above the Eleventh Rib (High Supracostal Approach) Versus Subcostal Puncture in Percutaneous Nephrolithotomy for Treatment of Renal Stones in Adults: A Prospective Randomized Trial",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Assiut University",
"sponsor_slug": "assiut-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150417",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06150417",
"title": "Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06853223",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06853223",
"title": "A Randomized Trial of CCR5 Inhibition as a Complement to Lung Transplant Induction Immunosuppression",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06822010",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06822010",
"title": "A Phase II Trial of SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma (SUMMIT)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150599",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06150599",
"title": "Sacral Neuromodulation for the Treatment of Chronic Pelvic Pain",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "William Beaumont Hospitals",
"sponsor_slug": "william-beaumont-hospitals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699849",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06699849",
"title": "A Phase 2/Phase 3, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Adaptive Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis",
"has_exemption": false,
"start_date": "2025-07-10",
"completion_date": "2028-04-04",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05719441",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05719441",
"title": "A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06646276",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06646276",
"title": "A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06894212",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06894212",
"title": "A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784726",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06784726",
"title": "Odronextamab for Relapsed/Refractory Large B-cell Lymphomas Before Definitive Lymphoma-Directed Therapies",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05156983",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05156983",
"title": "A Phase 3, Prospective, Randomized, Open-label, Adaptive Group Sequential, Multicenter Trial With Blinded Endpoint Assessment to Evaluate the Efficacy and Safety of TAK-330 for the Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation in Patients Requiring Urgent Surgery/Invasive Procedure",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260683",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06260683",
"title": "A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-Cigarettes on Smoking Behavior",
"has_exemption": false,
"start_date": "2024-04-10",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University Comprehensive Cancer Center",
"sponsor_slug": "ohio-state-university-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042438",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07042438",
"title": "A Phase 2 Randomized Trial of Remodeling Intestinal Microbiota Using Fecal Microbiome Transplant (FMT) Among Recipients of Chimeric Antigen Receptor T Cells (CAR T)",
"has_exemption": false,
"start_date": "2026-01-17",
"completion_date": "2028-04-13",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023432",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07023432",
"title": "Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-04-14",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04515836",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04515836",
"title": "Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma",
"has_exemption": false,
"start_date": "2021-02-19",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04988386",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04988386",
"title": "An Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants with Symptomatic Transthyretin Amyloid Cardiomyopathy Who Completed the Phase 3 ATTRibute-CM Trial (AG10-301)",
"has_exemption": false,
"start_date": "2021-10-27",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Eidos Therapeutics, a BridgeBio company",
"sponsor_slug": "eidos-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918431",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06918431",
"title": "A Phase 2 Study Evaluating the Safety and Efficacy of Asparaginase Erwinia Chrysanthemi- Recombinant-Rywn (Recombinant Erwinia Asparaginase) During Pediatric-Inspired Regimen in High-Risk Adults With Newly Diagnosed ALL or LBL",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05859568",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05859568",
"title": "Baseline Performance and Fitting Parameters for Sonova Products",
"has_exemption": false,
"start_date": "2023-04-17",
"completion_date": "2028-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Advanced Bionics",
"sponsor_slug": "advanced-bionics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973187",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06973187",
"title": "A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06129864",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06129864",
"title": "A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC)",
"has_exemption": false,
"start_date": "2023-12-14",
"completion_date": "2028-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01869114",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01869114",
"title": "A Phase II Study of Azacitidine and Sirolimus for the Treatment of High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Refractory to or Not Eligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2013-07-08",
"completion_date": "2028-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Cancer Center at Thomas Jefferson University",
"sponsor_slug": "sidney-kimmel-cancer-center-at-thomas-jefferson-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06907615",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06907615",
"title": "An Open-label, Multi-center, Global Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-04-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Henlius Biotech",
"sponsor_slug": "shanghai-henlius-biotech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06357533",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06357533",
"title": "A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations (TROPION-Lung10)",
"has_exemption": false,
"start_date": "2024-04-11",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788938",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06788938",
"title": "Tarlatamab in Advanced DLL3-Expressing Tumors Including Neuroendocrine Neoplasms",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06911502",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06911502",
"title": "A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) Vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2025-07-08",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05536349",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05536349",
"title": "Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2028-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06071767",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06071767",
"title": "A Phase I/IIa Randomized, Placebo-Controlled Trial of Conserved-Mosaic T-cell Vaccine in a Regimen With Vesatolimod and Broadly Neutralizing Antibodies in Adults Initiated on Suppressive Antiretroviral Therapy During Acute HIV-1",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06358872",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06358872",
"title": "Azithromycine Pour la Vie Des Enfants au Niger II",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01068249",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01068249",
"title": "A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2010-04-30",
"completion_date": "2028-04-30",
"has_results": true,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01760005",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01760005",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2012-12-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02718001",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02718001",
"title": "Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)",
"has_exemption": false,
"start_date": "2015-02-06",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03805789",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03805789",
"title": "A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft-versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study)",
"has_exemption": false,
"start_date": "2019-03-27",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04089059",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04089059",
"title": "A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)",
"has_exemption": false,
"start_date": "2020-01-10",
"completion_date": "2028-04-30",
"has_results": true,
"results_due": false,
"sponsor_name": "Endotronix, Inc.",
"sponsor_slug": "endotronix-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05269394",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05269394",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-12-22",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05243797",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05243797",
"title": "Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4",
"has_exemption": false,
"start_date": "2022-09-08",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting European Myeloma Network",
"sponsor_slug": "stichting-european-myeloma-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04922333",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04922333",
"title": "Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery",
"has_exemption": false,
"start_date": "2023-03-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05707377",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05707377",
"title": "A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients With Primary Membranous Nephropathy",
"has_exemption": false,
"start_date": "2023-04-17",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05681299",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05681299",
"title": "Effects of Administration of Growth Hormone, Without and With Liraglutide, on AgRP, Energy and Glucose Metabolism in Healthy and GH Deficient Humans",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05313243",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05313243",
"title": "Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05838287",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05838287",
"title": "Pioglitazone, Lipotoxicity, and Heart Failure With Preserved Ejection Fraction (HFpEF)",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05540574",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05540574",
"title": "Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children With Autism",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06020716",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06020716",
"title": "A Phase 4 Double Blinded Study With Two Different Interventions, Each With Two Arms, to Evaluate the Clinical Efficacy of Antibiotics and the Role of Microbiology, Immunology and Genetics in Children Aged 9-36 Months With Chronic Wet Cough.",
"has_exemption": false,
"start_date": "2023-08-16",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Helse Stavanger HF",
"sponsor_slug": "helse-stavanger-hf",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06007183",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06007183",
"title": "A Long-term Follow-up Study to Evaluate Safety and Immunogenicity of a Chikungunya Virus Virus-like Particle Vaccine (PXVX0317) in Healthy Adults and Adolescents After Either a Single or Booster Vaccination Dosing Regimen",
"has_exemption": false,
"start_date": "2023-08-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bavarian Nordic",
"sponsor_slug": "bavarian-nordic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05980000",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05980000",
"title": "Open-Label, Randomized Phase 2 Trial of Ramucirumab in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-Line Treatment of PD-L1 Positive, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (RM-HNSCC)",
"has_exemption": false,
"start_date": "2023-10-27",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06162611",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06162611",
"title": "Generating Evidence to Improve Same-day Etonogestrel (ENG) Implant Insertion for Emergency Contraception",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lori Gawron",
"sponsor_slug": "lori-gawron",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05383742",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05383742",
"title": "A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis: Improved Management With Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06109467",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06109467",
"title": "A Phase II Study Of Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Overexpressing Gastroesophageal Cancers",
"has_exemption": false,
"start_date": "2024-01-12",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05822362",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05822362",
"title": "Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial",
"has_exemption": false,
"start_date": "2024-01-19",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06257875",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06257875",
"title": "A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2024-03-23",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06346067",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06346067",
"title": "A Randomized, Open-label Phase III Study in Patients With Previously Treated Unresectable or Metastatic NRAS Mutant Cutaneous Melanoma Comparing the Combination of Naporafenib + Trametinib to Physician's Choice of Therapy (Dacarbazine, Temozolomide or Trametinib Monotherapy) With a Dose Optimization lead-in [SEACRAFT-2]",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Erasca, Inc.",
"sponsor_slug": "erasca-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05992831",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05992831",
"title": "Transcranial Magnetic Stimulation for MCI: A Phase II Dose-Response Study",
"has_exemption": false,
"start_date": "2024-06-18",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06411210",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06411210",
"title": "Obesity Complicating Type 1 Diabetes in Young Adults: Physiology and Impact of GLP-1 Analogue Anti-obesity Treatment on Cardiometabolic Risk Factors",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06547216",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06547216",
"title": "A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)",
"has_exemption": false,
"start_date": "2024-07-25",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06194851",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06194851",
"title": "A Randomized Clinical Trial Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06556693",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06556693",
"title": "Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy",
"has_exemption": false,
"start_date": "2024-10-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zoll Medical Corporation",
"sponsor_slug": "zoll-medical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06724237",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06724237",
"title": "A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients With Peripheral T Cell Lymphoma That Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eastern Cooperative Oncology Group",
"sponsor_slug": "eastern-cooperative-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712420",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06712420",
"title": "Neoadjuvant Chemotherapy Versus Upfront Surgery for Locally Advanced Resectable Gall Bladder Cancer : A Randomized Trial",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rajiv Gandhi Cancer Institute & Research Center, India",
"sponsor_slug": "rajiv-gandhi-cancer-institute-research-center-india",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722755",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06722755",
"title": "Optimizing Adherence to the Treatment of Sleep Apnea Among Patients With Stroke Undergoing Inpatient Rehabilitation",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788990",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06788990",
"title": "A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bicara Therapeutics",
"sponsor_slug": "bicara-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712355",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06712355",
"title": "A Phase III, Multisite, Double-blinded Randomized Trial of BNT327 in Combination With Chemotherapy (Etoposide/Carboplatin) Compared to Atezolizumab in Combination With Chemotherapy (Etoposide/Carboplatin) in Participants With First-line Extensive-stage Small-cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-03",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06767514",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06767514",
"title": "A Randomized, Double-blinded, Multiregional Phase 3 Study of Ivonescimab Versus Pembrolizumab for the First-line Treatment of Metastatic Non-small Cell Lung Cancer in Patients Whose Tumors Demonstrate High PD-L1 Expression",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Summit Therapeutics",
"sponsor_slug": "summit-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06859268",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06859268",
"title": "A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Retatrutide Treatment in the Maintenance of Weight Reduction in Individuals With Obesity",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858254",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06858254",
"title": "Standard Optimization of Autologous Stem Cells by Intranasal and Intravenous Administration to Treat Parkinson's Disease and Atypical Parkinsonism",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apeiron Research Center",
"sponsor_slug": "apeiron-research-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866275",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06866275",
"title": "Suramin for the Treatment of Autism Trial (STAT): A Randomized, Double Blind, Crossover Trial of KZ101 in a Male Pediatric Population With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2025-04-09",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Orange County",
"sponsor_slug": "childrens-hospital-of-orange-county",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06929286",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06929286",
"title": "COMparative Prospective Assessment Through Clinically Integrated Randomized Trials Evaluating Intravesical Treatments: The COMPARE IT Trial",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06931821",
"title": "Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899711",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06899711",
"title": "A Prospective Study to Evaluate the Protective Effects of External Cranial Prosthesis on Incidence of Sunken Flap Syndrome in Decompressive Craniectomy Patients",
"has_exemption": false,
"start_date": "2025-04-26",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06734039",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06734039",
"title": "Impact of Anatomy-Based Frequency (ABF) Allocations on Early Performance Outcomes in MED-EL Cochlear Implant Recipients",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Med-El Corporation",
"sponsor_slug": "med-el-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06636136",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06636136",
"title": "Transtibial Osseointegration Surgery Study (TOSS)",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Walter Reed National Military Medical Center",
"sponsor_slug": "walter-reed-national-military-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858787",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06858787",
"title": "The Validity of a Continuous Glucose Monitor in Diagnosing Gestational Diabetes: A Pilot Study",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957704",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06957704",
"title": "Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Federal University of São Paulo",
"sponsor_slug": "federal-university-of-sao-paulo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852365",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06852365",
"title": "Resistant Starch Usage in Polycystic Ovary Syndrome: Impact on Cardiometabolic Dysfunction and the Gut Microbiome (CORS-PCOS)",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06405607",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06405607",
"title": "Psilocybin vs Ketamine for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937086",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06937086",
"title": "A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06848140",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06848140",
"title": "Using High Definition Transcranial Direct Current Stimulation to Treat Verbal Retrieval Deficits Secondary to Chronic Traumatic Brain Injury (STIM-CTBI)",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06615752",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06615752",
"title": "A Phase I/II Study to Determine the Safety and Efficacy of a Combination of Green Tea and Quercetin With Docetaxel in Castration-resistant Prostate Cancer Patients",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Charles Drew University of Medicine and Science",
"sponsor_slug": "charles-drew-university-of-medicine-and-science",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06982521",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06982521",
"title": "A Phase 3 Open-Label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment With a CDK4/6 Inhibitor",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Relay Therapeutics, Inc.",
"sponsor_slug": "relay-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011719",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07011719",
"title": "A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcus Biosciences, Inc.",
"sponsor_slug": "arcus-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06835400",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06835400",
"title": "An Open-Label, Randomized, Two-stage Study to Determine Dose Optimization, Safety, and Noninferiority of Oral Paclitaxel + Encequidar Compared to IV Paclitaxel in Subjects With HER2 Negative Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Health Hope Pharma",
"sponsor_slug": "health-hope-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06996652",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06996652",
"title": "An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06320951",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06320951",
"title": "Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03567824",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03567824",
"title": "A Phase 2 Open Label Study of Magnesium L-Lactate Dihydrate (MLD10) 10 mEq Extended-Release Caplets Administered BID for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus Followed by a Blinded Random Off Phase",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmalyte Solutions LLC",
"sponsor_slug": "pharmalyte-solutions-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04214262",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04214262",
"title": "A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC",
"has_exemption": false,
"start_date": "2020-08-13",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04906408",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04906408",
"title": "The Effects of Post-Operative Interventions on Surgical Site Occurrences in Abdominal Wall Reconstructions: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2021-09-17",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764395",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05764395",
"title": "A Phase II Study to Evaluate the Safety and Efficacy of Rigosertib (ON 01910) Plus Pembrolizumab in Patients With Metastatic Melanoma Refractory to Immune Checkpoint Blockade",
"has_exemption": false,
"start_date": "2023-05-09",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05899153",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05899153",
"title": "Quantifying Patient-specific Changes in Neuromuscular Control in Cerebral Palsy: Adaptation and Biofeedback During Gait",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06029309",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06029309",
"title": "A Phase 1/2 Study of Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Alvaro Alencar, MD",
"sponsor_slug": "alvaro-alencar-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706284",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06706284",
"title": "Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Marzieh Salehi",
"sponsor_slug": "marzieh-salehi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06831058",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06831058",
"title": "A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909110",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06909110",
"title": "Viral Specific T-Lymphocytes by Cytokine Capture System (CCS) to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus After Hematopoietic Cell Transplantation or Solid Organ Transplantation and in Patients With Compromised Immunity",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jessie L. Alexander",
"sponsor_slug": "jessie-l-alexander",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940674",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06940674",
"title": "Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS)",
"has_exemption": false,
"start_date": "2025-06-13",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06930651",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06930651",
"title": "A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03424005",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03424005",
"title": "A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Treatment Combinations In Patients With Metastatic Breast Cancer (Morpheus-panBC)",
"has_exemption": false,
"start_date": "2018-03-30",
"completion_date": "2028-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06256588",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06256588",
"title": "A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate Dostarlimab as Sequential Therapy After Chemoradiation in Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-03-21",
"completion_date": "2028-05-04",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03701282",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03701282",
"title": "A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)",
"has_exemption": false,
"start_date": "2019-02-12",
"completion_date": "2028-05-07",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05562830",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05562830",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents With or Without Pembrolizumab in Participants With PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma (KEYMAKER-U04): Substudy 04A",
"has_exemption": false,
"start_date": "2022-11-16",
"completion_date": "2028-05-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05892068",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05892068",
"title": "Window of Opportunity Analysis of Pre-Operative Tucatinib for Surgically Resected HER2+ Brain Metastases: Understanding Mechanisms of Resistance",
"has_exemption": false,
"start_date": "2023-05-09",
"completion_date": "2028-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05874635",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05874635",
"title": "Use of Signos mHealth Platform in Participants With Non-Insulin Dependent Type 2 Diabetes: Weight and Blood Glucose",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2028-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Signos Inc",
"sponsor_slug": "signos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06414863",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06414863",
"title": "Treatment Effects of Invisalign Palatal Expander System and Hyrax Palatal Expander - A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-05-10",
"completion_date": "2028-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of the Pacific",
"sponsor_slug": "university-of-the-pacific",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04064060",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04064060",
"title": "A Phase 3b, Open-label, Single-arm, Rollover Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials",
"has_exemption": false,
"start_date": "2019-08-12",
"completion_date": "2028-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780670",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06780670",
"title": "PSMAcTION: A Phase II/III, Open-label, International, Multicenter, Randomized Study of AAA817 Versus Standard of Care in the Treatment of Adult Participants With PSMA Positive Metastatic Castration-resistant Prostate Cancer Who Progressed on or After [177Lu]Lu-PSMA Targeted Therapy",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06984523",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06984523",
"title": "A Phase II Single-Arm Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05650359",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05650359",
"title": "A Randomized and Controlled Study of the Use of Orthopulse Photobiomodulation for Acceleration of Orthodontic Tooth Movement With Fixed Appliances",
"has_exemption": false,
"start_date": "2022-10-13",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Biolux Technology GmbH",
"sponsor_slug": "biolux-technology-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846671",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06846671",
"title": "A Phase 3, Open-Label, Randomized Study of BGB-16673 Compared to Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab or Venetoclax Plus Rituximab Retreatment) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both BTK and BCL2 Inhibitors",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06954987",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06954987",
"title": "A Two Cohort, Randomized, Double-Blind, Placebo-Controlled, Phase II Multi-Center Signal-Finding Study of Venetoclax Combined With Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation Then Venetoclax Maintenance in Adult Patients With Acute Myeloid Leukemia in First Complete Remission: A MyeloMATCH Sub-Study",
"has_exemption": false,
"start_date": "2025-09-18",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608291",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05608291",
"title": "A Phase 3 Trial of Fianlimab (Anti-LAG-3) and Cemiplimab Versus Pembrolizumab in the Adjuvant Setting in Patients With Completely Resected High-risk Melanoma",
"has_exemption": false,
"start_date": "2023-01-16",
"completion_date": "2028-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015983",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07015983",
"title": "A Phase 2, Multicenter, Open-Label Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Participants With Active SLE (Including Lupus Nephritis) With Inadequate Response to Glucocorticoids and at Least 2 Immunosuppressants",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2028-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",
"sponsor_slug": "juno-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463587",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06463587",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to Assess the Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis(MyClad)",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",
"sponsor_slug": "merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-germany",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044726",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07044726",
"title": "Betadine vs Sterile Water for Periurethral Preparation Prior to Straight Catherization in the Clinic Setting: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2028-05-21",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05884333",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05884333",
"title": "Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults",
"has_exemption": false,
"start_date": "2023-05-22",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260163",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06260163",
"title": "A Phase 3 Randomized, Open-label Induction, Double-blind Maintenance, Parallel-group, Multicenter Protocol to Evaluate the Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2024-01-19",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424288",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06424288",
"title": "EASi-HF Preserved - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) ≥40%",
"has_exemption": false,
"start_date": "2024-06-17",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03581136",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03581136",
"title": "Phase II Multi-center Trial Evaluating 5 Fraction S-PBI (Stereotactic Partial Breast Irradiation) for Early Stage Breast Cancer Using the GammaPod",
"has_exemption": false,
"start_date": "2019-04-22",
"completion_date": "2028-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06685068",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06685068",
"title": "A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-11-13",
"completion_date": "2028-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03600883",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03600883",
"title": "A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100)",
"has_exemption": false,
"start_date": "2018-08-27",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06012695",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06012695",
"title": "A Phase Ib/II, Open-label Study of NBM-BMX As Monotherapy or in Combination with Radiotherapy and Temozolomide in Subjects with Solid Tumors or Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2023-08-11",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novelwise Pharmaceutical Corporation",
"sponsor_slug": "novelwise-pharmaceutical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05984277",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05984277",
"title": "A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC).",
"has_exemption": false,
"start_date": "2023-10-24",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986993",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06986993",
"title": "Impact of Semaglutide Administration on Tobacco Use Behavior and Related Mechanisms Among Smokers With Obesity",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05866562",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05866562",
"title": "Dupilumab in the Treatment of Pediatric Alopecia Areata",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679946",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06679946",
"title": "An Open-Label Extension Study to Assess the Safety and Efficacy of Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918977",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06918977",
"title": "Evaluation of a Novel Telemedicine Clinic for Patients With DM2 on Multiple Daily Insulin (MDI) Regimens",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06949228",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06949228",
"title": "Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ProMedica Health System",
"sponsor_slug": "promedica-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03047746",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03047746",
"title": "Unrelated And Partially Matched Related Donor Peripheral Blood Stem Cell Transplantation (PSCT) With TCR αβ + T Cell And B Cell Depletion For Patients With Acquired And Inherited Bone Marrow Failure",
"has_exemption": false,
"start_date": "2017-02-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03422302",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03422302",
"title": "Measuring the Effectiveness of a Continuous Positive Airway Pressure (CPAP) Device to Reduce Tumor Motion and Increase Lung Volume Expansion in Patients Undergoing Stereotactic Body Radiotherapy (SBRT) for Tumors That Move With Respiration",
"has_exemption": false,
"start_date": "2018-03-16",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04471974",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04471974",
"title": "A Phase 2 Study of BET Bromodomain Inhibitor ZEN-3694 in Combination With Enzalutamide Plus Pembrolizumab in Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-01-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rahul Aggarwal",
"sponsor_slug": "rahul-aggarwal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04411654",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04411654",
"title": "An Open-label, Phase 1/2 Study to Evaluate the Safety and Efficacy of Single-dose LY3884961 in Infants With Type 2 Gaucher Disease",
"has_exemption": false,
"start_date": "2021-06-29",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03742414",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03742414",
"title": "SEAL (Stopping Eczema and ALlergy) Study: Prevent the Allergic March by Enhancing the Skin Barrier",
"has_exemption": false,
"start_date": "2021-06-30",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kari Nadeau, MD, PhD",
"sponsor_slug": "kari-nadeau-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05083481",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05083481",
"title": "A Phase 1/2 Study of ASP1570 as Monotherapy and in Combination With Pembrolizumab or Standard Therapies Including Chemotherapy and/or Immunotherapy in Participants With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2021-10-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05045950",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05045950",
"title": "Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (ONCO-RT) - A Phase II Trial of Upfront Pulsed Reduced Dose Rate Whole-Brain Radiation Therapy for Brain Metastases",
"has_exemption": false,
"start_date": "2021-11-17",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05047172",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05047172",
"title": "Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)",
"has_exemption": false,
"start_date": "2022-08-02",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05508789",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05508789",
"title": "Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease",
"has_exemption": false,
"start_date": "2022-10-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05866536",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05866536",
"title": "Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years",
"has_exemption": false,
"start_date": "2023-05-04",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05943210",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05943210",
"title": "The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer.",
"has_exemption": false,
"start_date": "2023-05-22",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04796792",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04796792",
"title": "Ultrasound Technology to Fragment and Reposition Urinary Stones",
"has_exemption": false,
"start_date": "2023-07-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023589",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06023589",
"title": "A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children With Severe Uncontrolled Asthma (HORIZON)",
"has_exemption": false,
"start_date": "2023-08-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06003348",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06003348",
"title": "Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305039",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06305039",
"title": "Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments - Part 2",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, College Park",
"sponsor_slug": "university-of-maryland-college-park",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}